Louisiana 2022 2022 Regular Session

Louisiana House Bill HB768 Comm Sub / Analysis

                    DIGEST
The digest printed below was prepared by House Legislative Services.  It constitutes no part of the
legislative instrument.  The keyword, one-liner, abstract, and digest do not constitute part of the law
or proof or indicia of legislative intent.  [R.S. 1:13(B) and 24:177(E)]
HB 768 Original	2022 Regular Session	Marino
Abstract:  Increases the total number of therapeutic marijuana pharmacy licenses the Louisiana
Board of Pharmacy can issue and provides criteria for the selection of applicants receiving
any new licenses.
Present law limits the number of therapeutic marijuana pharmacy licenses issued by the La. Bd. of
Pharmacy to 10.
Proposed law increases the number of licenses provided in present law from 10 to 25.
Proposed law requires the La. Bd. of Pharmacy to develop rules for issuing new licenses based on
a minimum criterion of the following:
(1)Applicants who have resided within the state for at least five years prior to the date of
application or applicants who have owned property on which the pharmacy will be located
and have at least 51% ownership in the property for at least five years prior to the date of
application for a license.
(2)Prohibits a licensee from selling or transferring their license to another person that has not
been a Louisiana resident for at least five years prior to the sale or transfer or to an entity that
does not have an ownership group made up of at least 51% of La. residents residing in the
state at least five years prior to the sale or transfer.
(3)Any licensee receiving a license issued after Aug. 1, 2022 is prohibited from dispensing any
marijuana product for therapeutic use prior to Jan. 1, 2023.
Proposed law directs the La. Bd. of Pharmacy to begin accepting applications for new licenses after
60 days from when proposed law becomes effective.
(Amends R.S. 40:1046(G))